The influence of topical unsaturated fatty acids and essential oils on normal and atopic dogs
- PMID: 21673338
- DOI: 10.5326/JAAHA-MS-5607
The influence of topical unsaturated fatty acids and essential oils on normal and atopic dogs
Abstract
Seven dogs with atopic dermatitis and six normal dogs were treated with a spot-on product containing essential oils and unsaturated fatty acids q 7 days for 8 wk. Seven additional atopic dogs received a daily spray containing similar ingredients to the spot-on. In all dogs, transepidermal water loss (TEWL) was measured before and after treatment using a closed chamber device. In atopic dogs, a validated lesion score (canine atopic dermatitis extent and severity index, CADESI) was determined and pruritus was assessed with a visual analog scale before and after treatment. The mean CADESI scores in atopic dogs decreased with the spot-on (P=0.0043) and with the spray (P=0.0366). Similarly, the pruritus scores decreased with the spot-on (P=0.266) and with the spray (P=0.0177). There was a significant difference between the TEWL values of healthy and atopic dogs on the abdomen (P=0.0181) and back (P=0.0123). TEWL decreased significantly on the back after treatment with the spray (P=0.016), but not on the abdomen (P=0.078). Adverse effects were not observed. The results of this pilot study indicate that topical fatty acids and essential oils are a useful treatment option for canine atopic dermatitis.
Similar articles
-
The effect of a spot-on formulation containing polyunsaturated fatty acids and essential oils on dogs with atopic dermatitis.Vet J. 2014 Jan;199(1):39-43. doi: 10.1016/j.tvjl.2013.10.024. Epub 2013 Oct 29. Vet J. 2014. PMID: 24355814 Clinical Trial.
-
Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.Vet Dermatol. 2012 Feb;23(1):4-10, e1-2. doi: 10.1111/j.1365-3164.2011.00992.x. Epub 2011 Jul 1. Vet Dermatol. 2012. PMID: 21718368 Clinical Trial.
-
Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.Vet Dermatol. 2009 Jun;20(3):191-8. doi: 10.1111/j.1365-3164.2009.00756.x. Epub 2009 Apr 3. Vet Dermatol. 2009. PMID: 19374721 Clinical Trial.
-
Nonsteroidal, nonimmunosuppressive therapies for pruritus.Vet Clin North Am Small Anim Pract. 2013 Jan;43(1):173-87. doi: 10.1016/j.cvsm.2012.09.001. Vet Clin North Am Small Anim Pract. 2013. PMID: 23182331 Review.
-
Treating canine atopic dermatitis with unsaturated fatty acids: the role of mast cells and potential mechanisms of action.J Anim Physiol Anim Nutr (Berl). 2014 Dec;98(6):1013-20. doi: 10.1111/jpn.12181. Epub 2014 Mar 17. J Anim Physiol Anim Nutr (Berl). 2014. PMID: 24628699 Review.
Cited by
-
Canine Atopic Dermatitis: Prevalence, Impact, and Management Strategies.Vet Med (Auckl). 2024 Feb 13;15:15-29. doi: 10.2147/VMRR.S412570. eCollection 2024. Vet Med (Auckl). 2024. PMID: 38371487 Free PMC article. Review.
-
Primary Prevention of Canine Atopic Dermatitis: Breaking the Cycle-A Narrative Review.Vet Sci. 2023 Nov 16;10(11):659. doi: 10.3390/vetsci10110659. Vet Sci. 2023. PMID: 37999481 Free PMC article. Review.
-
Sphingomyelin-Rich Lipid Extract Collar for Canine Atopic Dermatitis.Vet Sci. 2023 Jun 7;10(6):389. doi: 10.3390/vetsci10060389. Vet Sci. 2023. PMID: 37368775 Free PMC article.
-
Skin Barrier Reinforcement Effect Assessment of a Spot-on Based on Natural Ingredients in a Dog Model of Tape Stripping.Vet Sci. 2022 Jul 28;9(8):390. doi: 10.3390/vetsci9080390. Vet Sci. 2022. PMID: 36006305 Free PMC article.
-
Enhanced In Vitro Expression of Filaggrin and Antimicrobial Peptides Following Application of Glycosaminoglycans and a Sphingomyelin-Rich Lipid Extract.Vet Sci. 2022 Jun 27;9(7):323. doi: 10.3390/vetsci9070323. Vet Sci. 2022. PMID: 35878340 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
